Efficacy and safety of efalizumab therapy in two pediatric patients with plaque psoriasis

被引：0
|
作者：
Turner, J [1 ]
机构：
[1] Mid S Dermatol & Skin Canc Ctr, Bartlett, TN USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P183 / P183
页数：1
相关论文
共 50 条
  • [41] Safety events in moderate to severe psoriasis patients treated with efalizumab
    Ehrlich, Alison
    Caro, Ivor
    Werther, Winifred
    Chen, Yun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
  • [42] Long-term safety and efficacy of efalizumab in the treatment of chronic plaque psoriasis: Interim data from the Canadian RESTORE study
    Papp, Kim
    Gilbert, Martin
    Wasel, Norman
    Gulliver, Wayne
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB175 - AB175
  • [43] Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis
    Mortensen, DL
    Walicke, PA
    Wang, XL
    Kwon, P
    Kuebler, P
    Gottlieb, AB
    Krueger, JG
    Leonardi, C
    Miller, B
    Joshi, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (03): : 286 - 298
  • [44] Analysis of efalizumab safety in patients with moderate to severe psoriasis and diabetes
    Chen, Yun
    Caro, Ivor
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB164 - AB164
  • [45] Sequential therapy in plaque psoriasis using the "Hit and Run" approach: infliximab followed by efalizumab
    Penz, Severine
    Pelletier, Fabien
    Riou-Gotta, Marie Odile
    Puzenat, Eve
    Levang, Julien
    Mermet, Isabelle
    Humbert, Philippe
    Aubin, Francois
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (02) : 236 - 237
  • [46] HLA-Cw6 polymorphism predict response to the biologic therapy efalizumab in patients with chronic plaque psoriasis
    Gulliver, Wayne
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB162 - AB162
  • [47] Biologics in pediatric psoriasis - efficacy and safety
    Dogra, Sunil
    Mahajan, Rahul
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (01) : 9 - 16
  • [48] Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis
    Langley, Richard G.
    Kasichayanula, Sree
    Trivedi, Mona
    Aras, Girish A.
    Kaliyaperumal, Arunan
    Yuraszeck, Theresa
    Gibbs, John
    Gibbs, Megan
    Kricorian, Greg
    Paller, Amy S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 340 - 346
  • [49] Safety of two courses of intravenous alefacept in patients with chronic plaque psoriasis
    Gordon, KB
    Menter, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 344 - 344
  • [50] Efficacy outcomes during extended and long-term use of efalizumab in patients with moderate to severe chronic plaque psoriasis
    Papp, K
    Menter, A
    Leonardi, C
    Lynde, C
    Ouellet, J
    Toth, D
    Rosoph, L
    Carey, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
12345